跳至主要内容
临床试验/NCT03284905
NCT03284905已完成不适用

Probiotic Intervention for Acute Stress

Probi AB2 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2017年10月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Probi AB
入组人数
70
试验地点
2
主要终点
Reduction of the cortisol level during acute stress

研究概览

简要总结

Efficacy of probiotics on acute stress

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 35 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 19-35 years
  • SMBQ-score ≥3.75
  • Understand Swedish in spoken and written terms
  • Willing and able to give written informed consent for participating in the study
  • Intake of probiotics within two weeks prior to the start of the study

排除标准

  • Antibiotic treatment in the last three months
  • Known disease (diabetes, pulmonary or cardiovascular disease, celiac disease, thyroid problems, gastrointestinal disease) or mental illness
  • Use of psychotropic drugs, beta blockers, asthma or rheumatoid arthritis drugs, steroid drugs or local steroid treatment

研究组 & 干预措施

Probiotics

Active Comparator

干预措施: Probiotic supplement (Dietary Supplement)

Placebo

Placebo Comparator

干预措施: Placebo supplement (Dietary Supplement)

结局指标

主要结局

Reduction of the cortisol level during acute stress

时间窗: 2.5 hours

次要结局

未报告次要终点

研究者

发起方
Probi AB
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验